Forums before death by AOL, social media and spammers... "We can't have nice things"
|    sci.med.psychobiology    |    Dialog and news in psychiatry and psycho    |    4,734 messages    |
[   << oldest   |   < older   |   list   |   newer >   |   newest >>   ]
|    Message 3,440 of 4,734    |
|    =?UTF-8?B?4oqZ77y/4oqZ?= to All    |
|    Alzheimer's Test Detects Disease Decade     |
|    17 Feb 15 20:12:58    |
      From: hound23x@gmail.com              Alzheimer's Test Detects Disease Decade Ahead of Onset              by Megan Scudellari       1:55 PM CST November 16, 2014                             Researchers found that patients with Alzheimer's had higher amounts of the       inactive form of the protein and lower amounts of the active form than healthy       individuals. Photographer: Junji Yoshino/Bloomberg       Nov. 17 (Bloomberg) -- A new blood test for Alzheimer's appears to detect the       disease as many as 10 years before clinical diagnosis is possible -- far       sooner than other tests in development.       The test, described publicly for the first time yesterday, could soon be used       to identify and treat patients with Alzheimer's earlier in their disease       progression. Those people could participate in clinical trials to help find       new treatments. Already,        the test distinguishes between patients and healthy elderly with 100 percent       accuracy.       "We will need replication and validation, but I'm very optimistic this work       will hold," Dimitrios Kapogiannis, the study's lead author and a       neuroscientist at the National Institute on Aging, said after a presentation       at the Society for Neuroscience        conference in Washington yesterday.              The blood test is still in the early stages of development and has only been       evaluated in 174 individuals, requiring a larger, long-term study before       widespread use, the authors said in a statement. NanoSomiX, an Aliso Viejo,       California-based biotech        company that develops blood assays for neurodegenerative diseases and is       sponsoring the study, plans to produce a commercial version of the test, the       company said in a separate statement.       Two other potential Alzheimer's blood tests were announced earlier this year.       One measures 10 fats in the bloodstream that appear to predict dementia with       90 percent accuracy within three years of its onset. Another uses 10 proteins       in the blood to        predict onset with 87 percent accuracy within a year.       At the National Institute on Aging, Kapogiannis and his team identified a       single protein in the brain involved in insulin signaling, called IRS-1, that       appears to be defective in Alzheimer's patients.       Exosome Pool       The researchers gathered blood samples from 70 individuals with Alzheimer's       disease, 20 cognitively normal elderly with diabetes, and 84 healthy adults.       Of the participants, 22 of the Alzheimer's patients provided samples taken one       to 10 years before        diagnosis.       From the samples, the researchers isolated exosomes, little lipid sacs that       bud off cell membranes and carry signals to other cells and tissues. From the       resulting pool of exosomes, they identified just those originating in the       brain, which contain IRS-1,        and measured the levels of the protein.       They found that patients with Alzheimer's had higher amounts of the inactive       form of the protein and lower amounts of the active form than healthy       individuals. The diabetics had intermediate levels.       These levels were so consistent that the team could predict whether a blood       sample came from an Alzheimer's patient, healthy individual, or a diabetic --       with no errors. This was true even for samples from Alzheimer's patients taken       10 years before they        were diagnosed.       "We were able to perfectly classify patients and controls," Kapogiannis said       during his presentation.       To contact the reporter on this story: Megan Scudellari in Washington at       mscudellari@bloomberg.net       To contact the editors responsible for this story: Crayton Harrison at       tharrison5@bloomberg.net Carlos Caminada, Nancy Moran                     http://www.bloomberg.com/news/articles/2014-11-16/alzheimer-s-bl       od-test-may-detect-disease-decade-before-onset              --- SoupGate-Win32 v1.05        * Origin: you cannot sedate... all the things you hate (1:229/2)    |
[   << oldest   |   < older   |   list   |   newer >   |   newest >>   ]
(c) 1994, bbs@darkrealms.ca